Citadel Advisors’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.6M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.41M | Sell |
|
|||||
|
2024
Q1 | $5.44M | Sell |
|
|||||
|
2023
Q4 | $15.3M | Buy |
|
|||||
|
2023
Q3 | $15.9M | Sell |
|
|||||
|
2023
Q2 | $21M | Sell |
|
|||||
|
2023
Q1 | $20.4M | Sell |
|
|||||
|
2022
Q4 | $10.4M | Sell |
|
|||||
|
2022
Q3 | $31.3M | Sell |
|
|||||
|
2022
Q2 | $11.9M | Buy |
|
|||||
|
2022
Q1 | $14M | Buy |
|
|||||
|
2021
Q4 | $32M | Buy |
|
|||||
|
2021
Q3 | $52.4M | Buy |
|